US Stock MarketDetailed Quotes

Sagimet Biosciences (SGMT)

Watchlist
  • 6.140
  • -0.120-1.92%
Close Jan 16 16:00 ET
  • 6.140
  • 0.0000.00%
Post 20:01 ET
199.68MMarket Cap-3.45P/E (TTM)

Sagimet Biosciences (SGMT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
47.98%-10.18M
-61.54%-9.1M
-134.15%-14.54M
-78.55%-42.44M
-55.64%-11.02M
-404.49%-19.57M
1.50%-5.63M
12.37%-6.21M
2.96%-23.77M
4.96%-7.08M
Net income from continuing operations
11.70%-12.91M
-27.94%-10.39M
-174.19%-18.18M
-63.46%-45.57M
-98.76%-16.2M
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
8.60%-27.88M
-13.29%-8.15M
Operating gains losses
----
----
----
----
----
----
----
----
-33.33%-4K
----
Other non cash items
0.00%37K
8.57%38K
8.33%39K
4.32%145K
2.78%37K
5.71%37K
2.94%35K
5.88%36K
6.92%139K
9.09%36K
Change In working capital
111.67%701K
-108.46%-125K
1,571.82%2.66M
-7.16%-1.05M
1,407.86%3.66M
-1,123.17%-6.01M
7,485.00%1.48M
85.69%-181K
-123.21%-978K
69.86%-280K
-Change in prepaid assets
80.85%-825K
-108.58%-35K
-207.34%-687K
99.47%-5K
679.36%3.26M
-463.27%-4.31M
-0.97%408K
1,829.73%640K
-166.30%-952K
-610.91%-562K
-Change in payables and accrued expense
194.16%1.56M
-104.67%-51K
533.50%3.39M
-855.83%-907K
38.75%444K
-219.51%-1.66M
375.51%1.09M
34.45%-782K
-95.88%120K
131.84%320K
-Change in other current liabilities
0.00%-37K
-77.27%-39K
0.00%-39K
6.85%-136K
0.00%-38K
0.00%-37K
38.89%-22K
-11.43%-39K
-6.57%-146K
-11.76%-38K
Cash from discontinued investing activities
Operating cash flow
47.98%-10.18M
-61.54%-9.1M
-134.15%-14.54M
-78.55%-42.44M
-55.64%-11.02M
-404.49%-19.57M
1.50%-5.63M
12.37%-6.21M
2.96%-23.77M
4.96%-7.08M
Investing cash flow
Cash flow from continuing investing activities
-87.98%75K
82.32%-13.29M
13.77%3.41M
-590.33%-61.68M
150.20%9.85M
624K
-687.16%-75.16M
-84.54%3M
139.30%12.58M
-460.93%-19.62M
Net investment purchase and sale
-87.98%75K
82.32%-13.29M
13.77%3.41M
-590.33%-61.68M
150.20%9.85M
--624K
-687.16%-75.16M
-84.54%3M
139.30%12.58M
-460.93%-19.62M
Cash from discontinued investing activities
Investing cash flow
-87.98%75K
82.32%-13.29M
13.77%3.41M
-590.33%-61.68M
150.20%9.85M
--624K
-687.16%-75.16M
-84.54%3M
139.30%12.58M
-460.93%-19.62M
Financing cash flow
Cash flow from continuing financing activities
274K
103.70%1K
0
21.65%104.82M
0
0
97.03%-27K
77,192.65%104.85M
118,136.99%86.17M
0
Net common stock issuance
--0
--0
--0
17.92%105.75M
--0
--0
--0
--105.75M
--89.68M
--3.52M
Proceeds from stock option exercised by employees
--274K
--1K
--0
1,800.00%114K
--0
--0
--0
--114K
-50.00%6K
--0
Net other financing activities
----
----
----
70.30%-1.05M
--0
--0
97.03%-27K
-648.53%-1.02M
-4,038.82%-3.52M
----
Cash from discontinued financing activities
Financing cash flow
--274K
103.70%1K
--0
21.65%104.82M
--0
--0
97.03%-27K
77,192.65%104.85M
118,136.99%86.17M
--0
Net cash flow
Beginning cash position
-55.89%42.33M
-63.39%64.72M
0.93%75.84M
47,456.33%75.14M
-24.38%77.01M
418.47%95.96M
1,332.78%176.78M
47,456.33%75.14M
-99.72%158K
4,466.91%101.84M
Current changes in cash
48.11%-9.83M
72.30%-22.39M
-110.94%-11.12M
-99.07%701K
95.60%-1.17M
-122.73%-18.95M
-1,409.85%-80.82M
734.47%101.64M
232.54%74.98M
-1,188.75%-26.7M
End cash Position
-57.81%32.5M
-55.89%42.33M
-63.39%64.72M
0.93%75.84M
0.93%75.84M
-24.38%77.01M
418.47%95.96M
1,332.78%176.78M
47,456.33%75.14M
47,456.33%75.14M
Free cash flow
47.98%-10.18M
-61.54%-9.1M
-134.15%-14.54M
-78.55%-42.44M
-55.64%-11.02M
-404.49%-19.57M
1.50%-5.63M
12.37%-6.21M
2.96%-23.77M
4.96%-7.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 47.98%-10.18M-61.54%-9.1M-134.15%-14.54M-78.55%-42.44M-55.64%-11.02M-404.49%-19.57M1.50%-5.63M12.37%-6.21M2.96%-23.77M4.96%-7.08M
Net income from continuing operations 11.70%-12.91M-27.94%-10.39M-174.19%-18.18M-63.46%-45.57M-98.76%-16.2M-130.11%-14.62M-19.65%-8.12M-0.64%-6.63M8.60%-27.88M-13.29%-8.15M
Operating gains losses ---------------------------------33.33%-4K----
Other non cash items 0.00%37K8.57%38K8.33%39K4.32%145K2.78%37K5.71%37K2.94%35K5.88%36K6.92%139K9.09%36K
Change In working capital 111.67%701K-108.46%-125K1,571.82%2.66M-7.16%-1.05M1,407.86%3.66M-1,123.17%-6.01M7,485.00%1.48M85.69%-181K-123.21%-978K69.86%-280K
-Change in prepaid assets 80.85%-825K-108.58%-35K-207.34%-687K99.47%-5K679.36%3.26M-463.27%-4.31M-0.97%408K1,829.73%640K-166.30%-952K-610.91%-562K
-Change in payables and accrued expense 194.16%1.56M-104.67%-51K533.50%3.39M-855.83%-907K38.75%444K-219.51%-1.66M375.51%1.09M34.45%-782K-95.88%120K131.84%320K
-Change in other current liabilities 0.00%-37K-77.27%-39K0.00%-39K6.85%-136K0.00%-38K0.00%-37K38.89%-22K-11.43%-39K-6.57%-146K-11.76%-38K
Cash from discontinued investing activities
Operating cash flow 47.98%-10.18M-61.54%-9.1M-134.15%-14.54M-78.55%-42.44M-55.64%-11.02M-404.49%-19.57M1.50%-5.63M12.37%-6.21M2.96%-23.77M4.96%-7.08M
Investing cash flow
Cash flow from continuing investing activities -87.98%75K82.32%-13.29M13.77%3.41M-590.33%-61.68M150.20%9.85M624K-687.16%-75.16M-84.54%3M139.30%12.58M-460.93%-19.62M
Net investment purchase and sale -87.98%75K82.32%-13.29M13.77%3.41M-590.33%-61.68M150.20%9.85M--624K-687.16%-75.16M-84.54%3M139.30%12.58M-460.93%-19.62M
Cash from discontinued investing activities
Investing cash flow -87.98%75K82.32%-13.29M13.77%3.41M-590.33%-61.68M150.20%9.85M--624K-687.16%-75.16M-84.54%3M139.30%12.58M-460.93%-19.62M
Financing cash flow
Cash flow from continuing financing activities 274K103.70%1K021.65%104.82M0097.03%-27K77,192.65%104.85M118,136.99%86.17M0
Net common stock issuance --0--0--017.92%105.75M--0--0--0--105.75M--89.68M--3.52M
Proceeds from stock option exercised by employees --274K--1K--01,800.00%114K--0--0--0--114K-50.00%6K--0
Net other financing activities ------------70.30%-1.05M--0--097.03%-27K-648.53%-1.02M-4,038.82%-3.52M----
Cash from discontinued financing activities
Financing cash flow --274K103.70%1K--021.65%104.82M--0--097.03%-27K77,192.65%104.85M118,136.99%86.17M--0
Net cash flow
Beginning cash position -55.89%42.33M-63.39%64.72M0.93%75.84M47,456.33%75.14M-24.38%77.01M418.47%95.96M1,332.78%176.78M47,456.33%75.14M-99.72%158K4,466.91%101.84M
Current changes in cash 48.11%-9.83M72.30%-22.39M-110.94%-11.12M-99.07%701K95.60%-1.17M-122.73%-18.95M-1,409.85%-80.82M734.47%101.64M232.54%74.98M-1,188.75%-26.7M
End cash Position -57.81%32.5M-55.89%42.33M-63.39%64.72M0.93%75.84M0.93%75.84M-24.38%77.01M418.47%95.96M1,332.78%176.78M47,456.33%75.14M47,456.33%75.14M
Free cash flow 47.98%-10.18M-61.54%-9.1M-134.15%-14.54M-78.55%-42.44M-55.64%-11.02M-404.49%-19.57M1.50%-5.63M12.37%-6.21M2.96%-23.77M4.96%-7.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More